Santhera Pharmaceuticals Holding AG Stock Xetra
Equities
S3F
CH0027148649
Pharmaceuticals
Sales 2023 | 103M 114M 105M 155M | Sales 2024 * | 51.09M 56.18M 51.66M 76.45M | Capitalization | 105M 115M 106M 157M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | 0.87 x |
Net cash position 2023 * | - 0 0 0 | Net cash position 2024 * | - 0 0 0 | EV / Sales 2024 * | 2.05 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 68.76% |
Latest transcript on Santhera Pharmaceuticals Holding AG
Managers | Title | Age | Since |
---|---|---|---|
Dario Eklund
CEO | Chief Executive Officer | 56 | 19-11-30 |
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Andrew P. Smith
DFI | Director of Finance/CFO | 61 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Director/Board Member | 56 | 17-04-03 | |
Otto Schwarz
BRD | Director/Board Member | 68 | 23-06-26 |
1st Jan change | Capi. | |
---|---|---|
+10.23% | 8.96B | |
-10.76% | 5.19B | |
+51.58% | 4.77B | |
+12.50% | 4.26B | |
-20.70% | 2.37B | |
+12.83% | 2.3B | |
+19.51% | 2.17B | |
-29.65% | 2.21B | |
-0.50% | 1.64B |